Progabid

Gefahreninformationscode (GHS)

• Bildanzeige (GHS)

  

• Alarmwort

  Warnung

• Gefahrenhinweise

  H302：Gesundheitsschädlich bei Verschlucken.

  H315：Verursacht Hautreizungen.

  H319：Verursacht schwere Augenreizung.

  H335：Kann die Atemwege reizen.

• Sicherheit

  P261：Einatmen von Staub vermeiden.

  P305+P351+P338：BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.

Progabide Chemische Eigenschaften,Einsatz,Produktion Methoden

• Beschreibung

  Progabide is a broad-spectrum anticonvulsant agent indicated for the treatment of a wide variety of seizure disorders. Synthesized as a GABA-prodrug, anticonvulsant activity appears due to the parent drug and its acid metabolite, as well as to GABAmide and GABA liberated therefrom.

• Chemische Eigenschaften

  Bright Yellow Solid

• Originator

  Synthelabo (France)

• Verwenden

  Progabide is a gamma-aminobutyric acid (GABA) antagonist with antiepileptic activity.

• Definition

  ChEBI: Progabide is a diarylmethane.

• Trademarks

  Gabren (Synthelabo Pharmacie, France);Gabaphore;Sl 76 002;GABRENE.

• Weltgesundheitsorganisation (WHO)

  Progabide, an anticonvulsant, was introduced in France in 1985 for the treatment of epilepsy. Its use has occasionally been associated with clinically evident signs of icteric hepatitis developing within the first six months of treatment. These signs are generally reversible on withdrawal of the drug but continuation of treatment has been associated with three reported fatalities (two of which are doubtfully related to the drug). The manufacturer revised the data sheet in March 1986 advising that use of progabide should be reserved for patients unresponsive to other anticonvulsants.

Progabide Upstream-Materialien And Downstream Produkte

Progabid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(53)Suppliers

62666-20-0, Progabide Verwandte Suche: